Login / Signup

Discovery of a Cryptic Intermediate in Late Steps of Mithramycin Biosynthesis.

Ryan WheelerXia YuCaixia HouPrithiba MitraJhong-Min ChenFrank HerkulesDmitri N IvanovOleg V TsodikovJürgen Rohr
Published in: Angewandte Chemie (International ed. in English) (2019)
MtmOIV and MtmW catalyze the final two reactions in the mithramycin (MTM) biosynthetic pathway, the Baeyer-Villiger opening of the fourth ring of premithramycin B (PMB), creating the C3 pentyl side chain, strictly followed by reduction of the distal keto group on the new side chain. Unexpectedly this results in a C2 stereoisomer of mithramycin, iso-mithramycin (iso-MTM). Iso-MTM undergoes a non-enzymatic isomerization to MTM catalyzed by Mg2+ ions. Crystal structures of MtmW and its complexes with co-substrate NADPH and PEG, suggest a catalytic mechanism of MtmW. The structures also show that a tetrameric assembly of this enzyme strikingly resembles the ring-shaped β subunit of a vertebrate ion channel. We show that MtmW and MtmOIV form a complex in the presence of PMB and NADPH, presumably to hand over the unstable MtmOIV product to MtmW, yielding iso-MTM, as a potential self-resistance mechanism against MTM toxicity.
Keyphrases
  • reactive oxygen species
  • oxidative stress
  • drug delivery
  • room temperature
  • human health
  • single cell